(Q35784097)

10 August 2017

1 reference

title

The therapeutic potential of ximelagatran to become the anticoagulant of choice in medicine: a review of recently completed clinical trials (English)

1 reference

10 August 2017

1 reference

Amar M Salam

1

1 reference

10 August 2017

Eyas N Al-Mousa

series ordinal

2

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

Expert Opinion on Pharmacotherapy

10 August 2017

published in

1 reference

10 August 2017

volume

5

1 reference

10 August 2017

issue

6

1 reference

10 August 2017

page(s)

1423-1430

1 reference

Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. SPORTIF II: a dose-guiding, tolerability, and safety study

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1423

Crossref

reference URL

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.6.1423

Crossref

reference URL

10.1517/14656566.5.6.1423

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference